Article
KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
Medicine - 28 May 2021
Zhang Deng Yong, Ma Shuo Shuo, Sun Wan-Liang, Lv Xue Chen Huang, Lu Zheng
Abstract excerpt
ABSTRACT: Cholangiocarcinoma (CCA) is one of the most common malignant tumors. Although gene-targeted therapies have significantly improved the outcome of many cancers, the results are still not satisfactory for patients with CCA. Owing to the lack of an effective biomarker for guiding clinical treatment and monitoring prognosis in patients with CCA, the purpose of this study was to identify a new biomarker that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
